High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression.

作者: Deborah K. Sokol , Demao Chen , Martin R. Farlow , David W. Dunn , Bryan Maloney

DOI: 10.1177/08830738060210062201

关键词: PsychiatryAcetylcholinesteraseAlzheimer's diseaseInternal medicinePsychologyNeurotrophic factorsAnabolismAutismCase-control studyAggressionEndocrinologyPoison control

摘要: Autism is characterized by restricted, repetitive behaviors and impairment in socialization communication. Although no neuropathologic substrate underlying autism has been found, the findings of brain overgrowth via neuroimaging studies increased levels brain-derived neurotrophic factor (BDNF) blood favor an anabolic state. We examined acetylcholinesterase, plasma neuronal proteins, secreted beta-amyloid precursor protein (APP), amyloid-beta 40 42 peptides children with without autism. Children severe aggression expressed at two or more times up to four than mild There was a trend for show higher nonamyloidogenic lower compared controls. This favors alpha-secretase pathway (anabolic), opposite what seen Alzheimer disease. Additionally, complex relationship between age, markers found.

参考文章(20)
Elaine K. Perry, Robert H. Perry, Neurochemistry of consciousness: cholinergic pathologies in the human brain. Progress in Brain Research. ,vol. 145, pp. 287- 299 ,(2004) , 10.1016/S0079-6123(03)45020-6
Gregory J. Moore, Proton magnetic resonance spectroscopy in pediatric neuroradiology Pediatric Radiology. ,vol. 28, pp. 805- 814 ,(1998) , 10.1007/S002470050470
John D. Belcher, Christopher J. Bryant, Julia Nguyen, Paul R. Bowlin, Miroslaw C. Kielbik, John C. Bischof, Robert P. Hebbel, Gregory M. Vercellotti, Transgenic sickle mice have vascular inflammation Blood. ,vol. 101, pp. 3953- 3959 ,(2003) , 10.1182/BLOOD-2002-10-3313
Debomoy Lahiri, Martin Farlow, Kumar Sambamurti, Nigel Greig, Ezio Giacobini, Lon Schneider, A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Current Drug Targets. ,vol. 4, pp. 97- 112 ,(2003) , 10.2174/1389450033346957
Xiao Zhang, Cholinergic Activity and Amyloid Precursor Protein Processing in Aging and Alzheimers Disease Current Drug Targets - Cns & Neurological Disorders. ,vol. 3, pp. 137- 152 ,(2004) , 10.2174/1568007043482499
E. Courchesne, C. M. Karns, H. R. Davis, R. Ziccardi, R. A. Carper, Z. D. Tigue, H. J. Chisum, P. Moses, K. Pierce, C. Lord, A. J. Lincoln, S. Pizzo, L. Schreibman, R. H. Haas, N. A. Akshoomoff, R. Y. Courchesne, Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study Neurology. ,vol. 57, pp. 245- 254 ,(2001) , 10.1212/WNL.57.2.245
Y.-W. GE, D. K. LAHIRI, Regulation of Promoter Activity of the APP Gene by Cytokines and Growth Factors Annals of the New York Academy of Sciences. ,vol. 973, pp. 463- 467 ,(2002) , 10.1111/J.1749-6632.2002.TB04684.X
Deborah K. Sokol, David W. Dunn, Mary Edwards-Brown, Judy Feinberg, Hydrogen proton magnetic resonance spectroscopy in autism: Preliminary evidence of elevated choline/creatine ratio Journal of Child Neurology. ,vol. 17, pp. 245- 249 ,(2002) , 10.1177/088307380201700401